"Persistently Elevated Plasma Concentrations of RIPK3, MLKL, HMGB1, and RIPK1 in Patients with COVID-19 in the Intensive Care Unit." American Journal of Respiratory Cell and Molecular Biology, 67(3), pp. 405–408

Supported by the Goethe Corona Fund of the Goethe University and University Hospital Frankfurt.

Author Contributions: U.H. designed research. K.R. performed experiments. K.R. and H.N. collected data. K.R., S.R.T., and U.H. performed the analyses. K.R., S.R.T., S.C., and U.H. wrote the manuscript with input from H.N., E.H.A., A.v.K., and K.Z. All authors critically revised and approved the manuscript.

This letter has a data supplement, which is accessible from this issue’s table of contents at www.atsjournals.org.

Author disclosures are available with the text of this letter at www.atsjournals.org.